Kang Li-Min, Xu Lei, Yu Fa-Kun, Zhang Fu-Wei, Lang Li
Department of Hepatobiliary and Pancreatic Surgery, Puer People's Hospital, Puer 665000, Yunnan Province, China.
Department of Outpatient, Puer People's Hospital, Puer 665000, Yunnan Province, China.
World J Gastrointest Surg. 2024 Dec 27;16(12):3650-3654. doi: 10.4240/wjgs.v16.i12.3650.
Malignant obstructive jaundice (MOJ) encompasses a range of diseases stemming from malignant tumors such as cholangiocarcinoma, pancreatic cancer, and primary liver cancer, among others, which cause obstruction in both intra- and extra-hepatic bile ducts. This obstruction may lead to elevated bilirubin levels, hepatic function impairment, and a low rate of successful surgical resection in clinical settings. There are various minimally invasive treatment options for MOJ, including endoscopic biliary drainage, ultrasound-guided procedures, and percutaneous biliary tract puncture drainage.
恶性梗阻性黄疸（MOJ）包括一系列由恶性肿瘤引起的疾病，如胆管癌、胰腺癌和原发性肝癌等，这些肿瘤会导致肝内和肝外胆管梗阻。这种梗阻可能导致胆红素水平升高、肝功能损害，并且在临床环境中手术切除成功率较低。对于恶性梗阻性黄疸有多种微创治疗选择，包括内镜下胆道引流、超声引导下操作以及经皮胆道穿刺引流。
